These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 12097994

  • 1. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Bernard LA, Bergman JN, Eichenfield LF.
    Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994
    [Abstract] [Full Text] [Related]

  • 2. Pimecrolimus in dermatology: atopic dermatitis and beyond.
    Gisondi P, Ellis CN, Girolomoni G.
    Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
    [Abstract] [Full Text] [Related]

  • 3. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.
    Hebert AA, Warken KA, Cherill R.
    Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913
    [Abstract] [Full Text] [Related]

  • 4. Topical pimecrolimus (Elidel) for treatment of atopic dermatitis.
    Med Lett Drugs Ther; 2002 May 27; 44(1131):48-50. PubMed ID: 12045753
    [No Abstract] [Full Text] [Related]

  • 5. Pimecrolimus in dermatology.
    Fabroni C, Lotti T.
    G Ital Dermatol Venereol; 2009 Jun 27; 144(3):321-5. PubMed ID: 19528913
    [Abstract] [Full Text] [Related]

  • 6. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA.
    Clin Ther; 2006 Dec 27; 28(12):1972-82. PubMed ID: 17296454
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov 27; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 8. Pimecrolimus: a review of pre-clinical and clinical data.
    Graham-Brown RA, Grassberger M.
    Int J Clin Pract; 2003 May 27; 57(4):319-27. PubMed ID: 12800465
    [Abstract] [Full Text] [Related]

  • 9. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H, Kaufmann R, Stough D, Heikkila H, Andriano K, Grinienko A, Jimenez P, Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group.
    Br J Dermatol; 2008 May 27; 158(5):1083-93. PubMed ID: 18341665
    [Abstract] [Full Text] [Related]

  • 10. Topical tacrolimus and pimecrolimus: future directions.
    Ling MR.
    Semin Cutan Med Surg; 2001 Dec 27; 20(4):268-74. PubMed ID: 11770914
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
    Ho VC, Gupta A, Kaufmann R, Todd G, Vanaclocha F, Takaoka R, Fölster-Holst R, Potter P, Marshall K, Thurston M, Bush C, Cherill R.
    J Pediatr; 2003 Feb 27; 142(2):155-62. PubMed ID: 12584537
    [Abstract] [Full Text] [Related]

  • 12. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP, Curran MP.
    Am J Clin Dermatol; 2010 Feb 27; 11(4):295-8. PubMed ID: 20509720
    [Abstract] [Full Text] [Related]

  • 13. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
    Hoetzenecker W, Ecker R, Kopp T, Stuetz A, Stingl G, Elbe-Bürger A.
    J Allergy Clin Immunol; 2005 Jun 27; 115(6):1276-83. PubMed ID: 15940147
    [Abstract] [Full Text] [Related]

  • 14. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
    Prescrire Int; 2004 Dec 27; 13(74):209-12. PubMed ID: 15599989
    [Abstract] [Full Text] [Related]

  • 15. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D.
    J Eur Acad Dermatol Venereol; 2006 Mar 27; 20(3):248-54. PubMed ID: 16503881
    [Abstract] [Full Text] [Related]

  • 16. Pimecrolimus. Novartis.
    Schopf RE.
    Curr Opin Investig Drugs; 2002 May 27; 3(5):720-4. PubMed ID: 12090545
    [Abstract] [Full Text] [Related]

  • 17. Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
    Eichenfield LF, Thaci D, de Prost Y, Puig L, Paul C.
    Dermatology; 2007 May 27; 215 Suppl 1():3-17. PubMed ID: 18174689
    [Abstract] [Full Text] [Related]

  • 18. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Ned Tijdschr Geneeskd; 2005 May 14; 149(20):1096-100. PubMed ID: 15932135
    [Abstract] [Full Text] [Related]

  • 19. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug 14; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 20. Atopic dermatitis: a new treatment paradigm using pimecrolimus.
    Weinberg JM, Bowerman JG, Brown SM, Gerstein D, Kane KS, Selevan J, Virdee S.
    J Drugs Dermatol; 2003 Apr 14; 2(2):131-40. PubMed ID: 12852364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.